MA Aiwen, XU Jiyang, CHEN Jun, XU Min. Values of N-terminal B-type natriuretic peptide and cardiac troponin I in evaluating disease condition of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 16-19. DOI: 10.7619/jcmp.202007005
Citation: MA Aiwen, XU Jiyang, CHEN Jun, XU Min. Values of N-terminal B-type natriuretic peptide and cardiac troponin I in evaluating disease condition of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 16-19. DOI: 10.7619/jcmp.202007005

Values of N-terminal B-type natriuretic peptide and cardiac troponin I in evaluating disease condition of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension

More Information
  • Received Date: January 10, 2020
  • Objective To explore the values of N-terminal B-type natriuretic peptide(NT-proBNP)and cardiac troponin I(cTnI)in evaluating disease condition of patients with chronic obstructive pulmonary disease(COPD)complicated with pulmonary hypertension(PH). Methods Totally 79 COPD patients with PH were selected as combined group, 87 COPD patients without PH were selected as non-combined group, and 40 healthy people were selected as control group. The indexes such as oxygenation index, 6-minute walking distance(6MWT), blood lactate, acute physiology and chronic health score Ⅱ(APACHE Ⅱ), rate of mechanical ventilation, average hospital stay, NT-proBNP level and cTnI level were compared between groups. Results There were significant differences in oxygenation index, 6MWT, blood lactate, APACHE Ⅱ score, mechanical ventilation rate and average hospital stay between combined group and non-combined group(P<0.05). The results of NT-proBNP, cTnI and the end diastolic diameter of right ventricle in the combined group were significantly higher than those in the non-combined group and the control group(P<0.05), and the levels of NT-proBNP and cTnI in the non-combined group were significantly higher than those in the control group(P<0.05). Multivariate Logistic regression analysis showed that NT-proBNP, cTnI, oxygenation - index and blood lactate were the influencing factors of mechanical ventilation in COPD patients(P<0.05). The sensitivity and specificity of NT-proBNP combined with cTnI were relatively higher in the diagnosis of COPD patients with PH. Conclusion NT-proBNP and cTnI are not only important in the diagnosis of COPD patients with PH, but also can predict the severity of disease and prognosis of patients, and they can be used as sensitive serum biomarkers in evaluation COPD patients with or without PH and right heart dysfunction.
  • Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure different proBNP-108 to BNP-32 ratios in atrial and ventricular overload[J]. Heart, 2010, 96: 432-439.
    乔中会, 李俊萍. 慢性阻塞性肺疾病急性加重期患者死亡原因探讨[J]. 临床肺科杂志, 2012, 17(7): 1309-1310.
    Han M K, Martinez F J. Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc, 2011, 8(4): 356-362.
    Criner G J, Bourbeau J, Diekemper R L, et al. Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline[J]. Chest, 2015, 147(4): 894-942.
    任立新, 周建军, 裴金宝, 等. COPD合并肺心病患者血NT-proBNP水平变化研究[J]. 临床肺科杂志, 2014, 19(7): 1217-1219.
    张敏. 应用多普勒超声心动图估测肺动脉高压的分析[J]. 华夏医学, 2006, 19(6): 1104-1105.
    中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 肺动脉高压筛查诊断与治疗专家共识[J]. 中华心血管病杂志, 2007, 35(11): 979-987.
    Pavasini R, Tavazzi G, Biscaglia S, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis[J]. Chron Respir Dis, 2017, 14(2): 117-126.
    Fisher C. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure[J]. Heart, 2003, 89(8): 879-881.
    Minai O A, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective[J]. Chest, 2010, 137(Suppl 6): 39S-51S.
    王娜娜, 孟自力, 陈亮, 等. 慢性阻塞性肺疾病并发肺动脉高压血清标志物研究[J]. 临床肺科杂志, 2016, 21(6): 1051-1055.
    Marcun R, Sustic A, Brguljan P M, et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease[J]. Int J Cardiol, 2012, 161(3): 156-159.
    Abroug F, Ouanes-Besbes L, Nciri N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers[J]. Am J Respir Crit Care Med, 2006, 174(9): 990-996.
    徐莉, 徐晓. 血清25(OH)D、Lp(a)和cTnI水平对慢性阻塞性肺疾病急性加重患者合并冠心病患者早期诊断的临床研究[J]. 临床肺科杂志, 2020, 25(1): 3-7.
    宋祝, 王蒙, 徐昕烨, 等. COPD与冠脉病变严重程度的相关性分析[J]. 国际呼吸杂志, 2017(12): 921-925.
    Fimognari F L, Scarlata S, Conte M E, et al. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2008, 3(1): 89-96.
  • Related Articles

    [1]MA Kaiyue, ZHANG Shu, HUANG Shixin, LI Xiaobo. Effect of Siwu Wuzi Decoction on vascular endothelial growth factor, transforming growth factor-β1 and inflammatory factor levels in patients with wet age-related macular degeneration[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 6-10. DOI: 10.7619/jcmp.20244475
    [2]HU Lele, WEI Yinyu, WANG Jinyan, ZHU Kunliang, LIU Guoying. Relationships of serum angiopoietin-like protein 4 and fibroblast growth factor 23 levels with severity and prognosis of patients with diabetes nephropathy[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 56-61. DOI: 10.7619/jcmp.20240358
    [3]XU Ying, XIAO Wenhuan, ZHAO Yilin, YANG Xiang, ZHONG Yunian. Relationship between cognitive function and fibroblast growth factor-2 in patients with schizophrenia and its gender difference[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 64-69. DOI: 10.7619/jcmp.20220046
    [4]HOU Baozhou, LI Huiping, WEI Sichen, MU Zongwei, LI Lijuan, TIAN Shuying. Clinical significance of serum vascular endothelial growth factor, soluble thymidine kinase-1 and T lymphocyte subsets in patients with primary hepatocellular carcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 98-102. DOI: 10.7619/jcmp.20214756
    [5]HAN Bei, HAN Junling, CAO Jinghao, YU Yang, GONG Qin. Relation between intact fibroblast growth factor 23 and renal anemia in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 114-118. DOI: 10.7619/jcmp.20213812
    [6]CAI Liying, LUO Gang. Expression and significance of serum chemokine and fibroblast growth factor 21 in patients with diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 76-80. DOI: 10.7619/jcmp.20211123
    [7]YANG Song, WANG Chaonan, GU Yuanyuan. Research advance in correlations between fibroblast growth factor-21 and occurrence as well as development of vascular complications of type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(15): 128-132. DOI: 10.7619/jcmp.20210947
    [8]ZOU Xianjun, LI Hai, SUN Liang. Effect of Fufang Jingjie Fumigation Lotion on postoperativewound healing and expression of serum growth factors in patients after perianal abscess surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 74-77. DOI: 10.7619/jcmp.20201801
    [9]WU Dingyong. Effect of anti-vascular endothelial growth factor in treating diabetic macular edema[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 106-109. DOI: 10.7619/jcmp.202023032
    [10]BU Chi-wen, YANG Quan-de, LIU Jing-hong, CHEN Qian. Expressions and significance of pituitary tumor - transforming gene and basic fibroblast growth factor in breast carcinoma[J]. Journal of Clinical Medicine in Practice, 2012, (7): 18-20. DOI: 10.3969/j.issn.1672-2353.2012.07.005

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return